Successful use of continuous subcutaneous Foslevodopa/Foscarbidopa in Parkinson's disease with bipolar disorder without psychiatric destabilization

Clinical Parkinsonism & Related Disorders · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles